PT - JOURNAL ARTICLE AU - Sánchez-Romero, Luz M AU - Sagaceta-Mejía, Janine AU - Mindell, Jennifer S AU - Passi-Solar, Álvaro AU - Bernabé-Ortiz, Antonio AU - Tolentino-Mayo, Lizbeth AU - Moody, Alison AU - Scholes, Shaun TI - Sex differences in the secular change in waist circumference relative to body mass index in the Americas and England from 1997 to 2020 AID - 10.1101/2023.12.10.23299756 DP - 2023 Jan 01 TA - medRxiv PG - 2023.12.10.23299756 4099 - http://medrxiv.org/content/early/2023/12/11/2023.12.10.23299756.short 4100 - http://medrxiv.org/content/early/2023/12/11/2023.12.10.23299756.full AB - Objective To quantify changes over time in waist circumference (WC) relative to body mass index (BMI) by sex in the Americas (United States of America, Mexico, Chile, Peru) and England.Methods Data from adults aged 25-64 years between 1997 and 2020 was analysed; US data was stratified by racial-ethnic groups. Sex-specific BMI and WC means, and obesity and abdominal obesity prevalence, were compared between the first and last surveys. Using data from all survey years, secular changes across the BMI and WC distributions were estimated applying quantile regression models. BMI was added as a predictor of WC to estimate secular changes in WC relative to BMI. Interaction terms were included in all models to evaluate differences by sex.Results BMI and WC (except Peru) showed larger secular increases at the upper-tails of the distributions in both sexes. Increases at the 50th and 75th WC centiles relative to BMI were more pronounced in women than in men, with larger increases in US non-Hispanic whites and in England. In men, increases in WC independently of BMI were most evident in Mexico.Conclusions Disease risk associated with visceral fat, is potentially underestimated by national surveillance efforts that quantify secular changes only in BMI.Competing Interest StatementThe authors have declared no competing interest.Funding StatementSanchez-Romero is funded by the FDA Center for Tobacco Products (CTP) National Cancer Institute of National Institutes of Health K01CA260378. Sagaceta-Meja and Tolentino-Mayo are funded by Bloomberg Philanthropies. Tolentino-Mayo is funded by the National Council of Humanities Science and Technology, Mexico. No external funding was received by Mindell, Passi-Solar, Bernabe-Ortiz, Moody and Scholes.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Source data were openly available before the initiation of the study. Chile: National health survey databases are freely available on the Ministry of Health website (http://epi.minsal.cl/bases-de-datos). Mexico: The data underlying this study were generated by the National Institute of Public Health, and are freely available (https://ensanut.insp.mx/). Peru: The data underlying this study can be found in the repository National Open Data Plataform (https://www.datosabiertos.gob.pe/) and are freely accessible. US: NHANES datasets are publicly available at the CDC website (https://www.cdc.gov/nchs/nhanes/index.htm) England: The Health Survey for England datasets generated and analysed during the current study are available via the UK Data Service (UKDS: https://ukdataservice.ac.uk/), subject to their End-user Licence.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesSource data were openly available before the initiation of the study. Chile: National health survey databases are freely available on the Ministry of Health website (http://epi.minsal.cl/bases-de-datos). Mexico: The data underlying this study were generated by the National Institute of Public Health, and are freely available (https://ensanut.insp.mx/). Peru: The data underlying this study can be found in the repository National Open Data Plataform (https://www.datosabiertos.gob.pe/) and are freely accessible. US: NHANES datasets are publicly available at the CDC website (https://www.cdc.gov/nchs/nhanes/index.htm) England: The Health Survey for England datasets generated and analysed during the current study are available via the UK Data Service (UKDS: https://ukdataservice.ac.uk/), subject to their End-user Licence.http://epi.minsal.cl/bases-de-datoshttps://ensanut.insp.mx/https://www.datosabiertos.gob.pe/https://www.cdc.gov/nchs/nhanes/index.htm https://ukdataservice.ac.uk/BMIbody mass indexcmcentimetresENDESEncuesta Demográfica y de Salud Familiar (Peruvian Health Survey)ENSEncuesta Nacional de Salud (Chilean Health Survey)ENSANUTEncuesta Nacional de Salud y Nutrición (Mexican Health Survey)HEShealth examination surveysHSEHealth Survey for EnglandNHnon-HispanicNHANESNational Health and Nutrition Examination SurveyPPpercentage pointsWCwaist circumferenceWHOWorld Health Organization